60 Degrees Pharmaceuticals Inc (SXTP): Next-Year EPS Estimate 35.05%
As of 2026-06-11, 60 Degrees Pharmaceuticals Inc (SXTP) has a next-year EPS growth estimate of 35.05%.
On 2026-05-24, analyst consensus for SXTP's next-year EPS growth shifted from 77.85% to 35.05% — a negative change of 42.80 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at 71.91%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 35.05%
- EPS growth this year
- 71.91%
- EPS next quarter (est)
- -$0.73
- Last price
- $1.38
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 35.05% | 71.91% | -$0.73 | $1.38 |
| 2026-06-10 | 35.05% | 71.91% | -$0.73 | $1.38 |
| 2026-06-09 | 35.05% | 71.91% | -$0.73 | $1.39 |
| 2026-06-08 | 35.05% | 71.91% | -$0.73 | $1.43 |
| 2026-06-07 | 35.05% | 71.91% | -$0.73 | $1.42 |
| 2026-06-04 | 35.05% | 71.91% | -$0.73 | $1.53 |
| 2026-06-03 | 35.05% | 71.91% | -$0.73 | $1.45 |
| 2026-06-02 | 35.05% | 71.91% | -$0.73 | $1.47 |
| 2026-06-01 | 35.05% | 71.91% | -$0.73 | $1.46 |
| 2026-05-31 | 35.05% | 71.91% | -$0.73 | $1.49 |
| 2026-05-28 | 35.05% | 71.91% | -$1.28 | $1.49 |
| 2026-05-27 | 35.05% | 71.91% | -$1.28 | $1.41 |
| 2026-05-26 | 35.05% | 71.91% | -$1.28 | $1.50 |
| 2026-05-25 | 35.05% | 71.91% | -$1.28 | $1.48 |
| 2026-05-24 | 35.05% | 71.91% | -$1.28 | $1.48 |
| 2026-05-21 | 77.85% | 73.06% | -$1.14 | $1.49 |
| 2026-05-20 | 77.85% | 73.06% | -$1.14 | $1.40 |
| 2026-03-31 | 63.51% | N/A | N/A | $1.75 |
| 2026-03-30 | 63.51% | N/A | N/A | $1.51 |
| 2026-03-30 | 63.51% | N/A | N/A | $1.51 |
| 2026-03-30 | 63.51% | N/A | N/A | $1.51 |
| 2026-03-29 | 63.51% | N/A | N/A | $1.50 |
| 2026-03-29 | 63.51% | N/A | N/A | $1.50 |
| 2026-03-27 | 56.57% | N/A | N/A | $1.50 |
| 2026-03-26 | 56.57% | N/A | N/A | $1.49 |
| 2026-03-26 | 56.57% | N/A | N/A | $1.49 |
| 2026-03-26 | 56.57% | N/A | N/A | $1.49 |
| 2026-03-25 | 56.57% | N/A | N/A | $1.55 |
| 2026-03-25 | 56.57% | N/A | N/A | $1.55 |
| 2026-03-25 | 56.57% | N/A | N/A | $1.55 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is 60 Degrees Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, 60 Degrees Pharmaceuticals Inc (SXTP) has a next-year EPS growth estimate of 35.05%, based on analyst consensus.
When was the latest EPS estimate revision for SXTP?▾
The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 77.85% to 35.05%.
What sector and industry does 60 Degrees Pharmaceuticals Inc belong to?▾
60 Degrees Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SXTP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. 60 Degrees Pharmaceuticals Inc (SXTP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports